The impact of HIV-associated anaemia on the incidence of red blood cell transfusion: Implications for blood services in HIV-endemic countries

Transfusion and Apheresis Science

Volumn 51, Issue 3, 2014, Pages 10-18

  van den Berg, Karin ^a,b   Murphy, Edward L ^c,d   Pretorius, Lelanie ^b,e   Louw, Vernon J ^b  

^a SOUTH AFRICAN NATIONAL BLOOD SERVICE   (South Africa)

^b UNIVERSITY OF THE FREE STATE   (South Africa)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^e Ampath Trust   (South Africa)

Author keywords

Anaemia; Antiretroviral therapy; Blood utilisation; HIV AIDS; South Africa

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; ANTIVIRAL THERAPY; BLOOD BANK; BLOOD SAMPLING; COHORT ANALYSIS; CYTOPENIA; ENDEMIC DISEASE; ERYTHROCYTE TRANSFUSION; EXPECTATION; HIV ASSOCIATED ANEMIA; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; PREVALENCE; REVIEW; SOUTH AFRICA; VASCULARIZATION; ACQUIRED IMMUNODEFICIENCY SYNDROME; BLOOD DONOR; BLOOD SAFETY; COMPLICATION; DONOR SELECTION; SUPPLY AND DISTRIBUTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANEMIA; BLOOD DONORS; BLOOD SAFETY; DONOR SELECTION; ERYTHROCYTE TRANSFUSION; HUMANS; PREVALENCE; SOUTH AFRICA;

EID: 84928329762     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2014.10.012     Document Type: Review

References (81)

1. Barnett T., Whiteside A., Desmond C. The social and economic impact of HIV/AIDS in poor countries: a review of studies and lessons. Prog Dev Stud 2001, 1:151-170.
2. Joint United Nations Programme on HIV/AIDS (UNAIDS) UNAIDS World AIDS day report 2013 Geneva: UNAIDS, accessed 23.11.13. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/JC2434_WorldAIDSday_results_en.pdf.
3. Joint United Nations Programme on HIV/AIDS (UNAIDS), (WHO) WHO Fund UNCs. Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011 Geneva: UNAIDS, accessed 20.04.12. http://www.who.int/hiv/pub/progress_report2011/hiv_full_report_2011.pdf.
4. Joint United Nations Programme on HIV/AIDS (UNAIDS), (WHO) WHO AIDS epidemic update: December 2007 Geneva: UNAIDS, accessed 20.04.12. http://data.unaids.org/pub/epislides/2007/2007_epiupdate_en.pdf.
5. South African Department of Health The national HIV and syphilis prevalence survey South Africa 2007. Pretoria: Department of Health, accessed 20.04.12. http://www.unaids.org/en/dataanalysis/epidemiology/countryestimationreports/20080904_southafrica_anc_2008_en.pdf.
6. Joint United Nations Programme on HIV/AIDS (UNAIDS), Organisation WH. HIV/AIDS epidemiological surveillance report for the WHO African Region: 2007 update. Geneva: Joint United Nations Programme on HIV/AIDS, 2007.
7. Statistics South Africa Mid-year population estimates Pretoria: Statistics South Africa; 2013 July 2012, accessed 23.11.13. http://www.statssa.gov.za/publications/P0302/P03022013.pdf.
8. Joint United Nations Programme on HIV/AIDS (UNAIDS), World Health Organisation (WHO) AIDS Epidemic Update: November 2009: UNAIDS accessed 20.08.11. http://www.unaids.org/en/media/unaids/contentassets/dataimport/pub/report/2009/jc1700_epi_update_2009_en.pdf.
9. Joint United Nations Programme on HIV/AIDS (UNAIDS) UNAIDS 2013. AIDS by the numbers 2013, UNAIDS, Geneva, accessed 23.11.13. http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2013/JC2571_AIDS_by_the_numbers_en.pdf.
10. Joint United Nations Programme on HIV/AIDS (UNAIDS), World Health Organisation (WHO). UNAIDS annual report 2008: towards universal access. Geneva: UNAIDS, 2008.
11. Joint United Nations Programme on HIV/AIDS (UNAIDS) UNAIDS World AIDS Day Report. 2012 Geneva: UNAIDS, accessed 23.11.13. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/jc2434_worldaidsday_results_en.pdf.
12. Johnson L.F. Access to antiretroviral treatment in South Africa, 2004-2011. South Afr J HIV Med 2012, 13:22-27. accessed 28.04.12. http://www.sajhivmed.org.za/index.php/sajhivmed/article/view/805.
13. Statistics South Africa Mid-year population estimates 2011 2011, Statistics South Africa, Pretoria. http://www.statssa.gov.za/publications/P0302/P03022011.pdf.
14. Statistics South Africa Mid-year population estimates 2011 2012, Statistics South Africa, Pretoria, accessed 23.11.13, July 2012. http://www.statssa.gov.za/publications/P0302/P03022011.pdf.
15. Colvin M. Impact of AIDS - the health care burden. HIV/AIDS in South Africa 2005, Cambridge University Press, Cambridge. S. Abdool Karim, Q. Abdool Karim (Eds.).
16. PEPFAR Celebrating life: the U.S. President's Emergency Plan for AIDS relief 2009 annual report to Congress on PEPFAR Washington: PEPFAR, accessed 10.05.12. http://www.pepfar.gov/press/fifth_annual_report/.
17. Larson H.J., Bertozzi S., Piot P. Redesigning the AIDS response for long-term impact. Bull World Health Organ 2011, 89:846-852. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=22084531%26site=ehost-live.
18. Piot P. AIDS: from crisis management to sustained strategic response. Lancet 2006, 368:526-530. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=16890840%26site=ehost-live.
19. Hassig S.E., Perriëns J., Baende E., et al. An analysis of the economic impact of HIV infection among patients at Mama Yemo Hospital, Kinshasa, Zaire. AIDS 1990, 4:883-887. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=2252561%26site=ehost-live.
20. Scitovsky A.A., Cline M., Lee P.R. Medical care costs of patients with AIDS in San Francisco. JAMA 1986, 256:3103-3106. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=3783846%26site=ehost-live.
21. Seage G.R., Landers S., Barry A., Groopman J., Lamb G.A., Epstein A.M. Medical care costs of AIDS in Massachusetts. JAMA 1986, 256:3107-3109. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=3491224%26site=ehost-live.
22. Colvin M., Dawood S., Kleinschmidt I., Mullick S., Lallo U. Prevalence of HIV and HIV-related diseases in the adult medical wards of a tertiary hospital in Durban, South Africa. Int J STD AIDS 2001, 12:386-389. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=11368820%26site=ehost-live.
23. Pillay K., Colvin M., Williams R., Coovadia H.M. Impact of HIV-1 infection in South Africa. Arch Dis Child 2001, 85:50-51. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=11420200%26site=ehost-live.
24. Floyd K., Reid R.A., Wilkinson D., Gilks C.F. Admission trends in a rural South African hospital during the early years of the HIV epidemic. JAMA 1999, 282:1087-1091. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=10493210%26site=ehost-live.
25. Collins P.Y., Berkman A., Mestry K., Pillai A. HIV prevalence among men and women admitted to a South African public psychiatric hospital. AIDS Care 2009, 21:863-867. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=20024743%26site=ehost-live.
26. Buvé A. AIDS and hospital bed occupancy: an overview. Trop Med Int Health 1997, 2:136-139. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=9472298%26site=ehost-live.
27. Gilks C.F., Floyd K., Otieno L.S., Adam A.M., Bhatt S.M., Warrell D.A. Some effects of the rising case load of adult HIV-related disease on a hospital in Nairobi. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18:234-240. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=9665500%26site=ehost-live.
28. Bateman C. Can KwaZulu-Natal hospitals cope with the HIV AIDS human tide?. S Afr Med J 2001, 91:364-368. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=11455795%26site=ehost-live.
29. Meyers T.M., Pettifor J.M., Gray G.E., Crewe-Brown H., Galpin J.S. Pediatric admissions with human immunodeficiency virus infection at a regional hospital in Soweto, South Africa. J Trop Pediatr 2000, 46:224-230. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=10996984%26site=ehost-live.
30. Martinson N.A., Omar T., Gray G.E., et al. High rates of HIV in surgical patients in Soweto, South Africa: impact on resource utilisation and recommendations for HIV testing. Trans R Soc Trop Med Hyg 2007, 101:176-182. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=16814822%26site=ehost-live.
31. Cacala S.R., Mafana E., Thomson S.R., Smith A. Prevalence of HIV status and CD4 counts in a surgical cohort: their relationship to clinical outcome. Ann R Coll Surg Engl 2006, 46-51.
32. Evans R.H., Scadden D.T. Haematological aspects of HIV infection. Baillieres Best Pract Res Clin Haematol 2000, 13:215-230. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=10942622%26site=ehost-live.
33. Sullivan P.S., Hanson D.L., Chu S.Y., Jones J.L., Ward J.W. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998, 91:301-308. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=9414298%26site=ehost-live.
34. Coyle T.E. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med Clin North Am 1997, 81:449-470. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=9093237%26site=ehost-live.
35. Bain B.J. The haematological features of HIV infection. Br J Haematol 1997, 99:1-8. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=9359495%26site=ehost-live.
36. Sullivan P. Associations of anemia, treatments for anemia, and survival in patients with human immunodeficiency virus infection. J Infect Dis 2002, 185(Suppl. 2):S138-S142. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=12001035%26site=ehost-live.
37. Moore R.D., Keruly J.C., Chaisson R.E. Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 19:29-33. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=9732065%26site=ehost-live.
38. Kimel M., Leidy N.K., Mannix S., Dixon J. Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV/AIDS, and chronic kidney disease. Value Health 2008, 11:57-75. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=18237361%26site=ehost-live.
39. Volberding P. The impact of anemia on quality of life in human immunodeficiency virus-infected patients. J Infect Dis 2002, 185(Suppl. 2):S110-S114. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=12001031%26site=ehost-live.
40. Revicki D.A., Brown R.E., Henry D.H., McNeill M.V., Rios A., Watson T. Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia. J Acquir Immune Defic Syndr 1994, 7:474-484. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=8158542%26site=ehost-live.
41. Abrams D.I., Steinhart C., Frascino R. Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of life. Int J STD AIDS 2000, 11:659-665. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=11057937%26site=ehost-live.
42. Bolge S.C., Mody S., Ambegaonkar B.M., McDonnell D.D., Zilberberg M.D. The impact of anemia on quality of life and healthcare resource utilization in patients with HIV/AIDS receiving antiretroviral therapy. Curr Med Res Opin 2007, 23:803-810. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=17407637%26site=ehost-live.
43. Van den Berg K., van Hasselt J., Bloch E., et al. A review of the use of blood and blood products in HIV-infected patients. South Afr J HIV Med 2012, 13:87-103.
44. Kiragga A.N., Castelnuovo B., Nakanjako D., Manabe Y.C. Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings. J Int AIDS Soc 2010, 13:42. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=21047391%26site=ehost-live.
45. Volberding P.A., Levine A.M., Dieterich D., Mildvan D., Mitsuyasu R., Saag M. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis 2004, 38:1454-1463. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=15156485%26site=ehost-live.
46. Telen M.J., Roberts K.B., Bartlett J.A. HIV-associated autoimmune hemolytic anemia: report of a case and review of the literature. J Acquir Immune Defic Syndr 1990, 3:933-937. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=2204697%26site=ehost-live.
47. Olayemi E., Awodu O.A., Bazuaye G.N. Autoimmune hemolytic anemia in HIV-infected patients: a hospital based study. Ann Afr Med 2008, 7:72-76. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=19143163%26site=ehost-live.
48. Gunther K., Garizio D., Dhlamini B. The pathogenesis of HIV-related thrombotic thrombocytopaemic purpura - is it different?. ISBT Sci Ser 2006, 1:246-250.
49. Novitzky N., Thomson J., Abrahams L., du Toit C., McDonald A. Thrombotic thrombocytopenic purpura in patients with retroviral infection is highly responsive to plasma infusion therapy. Br J Haematol 2005, 128:373-379. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=15667540%26site=ehost-live.
50. Thompson C.E., Damon L.E., Ries C.A., Linker C.A. Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 1992, 80:1890-1895. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=1391952%26site=ehost-live.
51. Hymes K.B., Karpatkin S. Human immunodeficiency virus infection and thrombotic microangiopathy. Semin Hematol 1997, 34:117-125. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=9109213%26site=ehost-live.
52. Becker S., Fusco G., Fusco J., et al. HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: an observational study. Clin Infect Dis 2004, 39(Suppl. 5):S267-S275. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=15494898%26site=ehost-live.
53. Gunther K., Garizio D., Nesara P. ADAMTS13 activity and the presence of acquired inhibitors in human immunodeficiency virus-related thrombotic thrombocytopenic purpura. Transfusion 2007, 47:1710-1716. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=17725738%26site=ehost-live.
54. Visagie G.J., Louw V.J. Myocardial injury in HIV-associated thrombotic thrombocytopenic purpura (TTP). Transfus Med 2010, 20:258-264. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=20409074%26site=ehost-live.
55. Meiring M., Webb M., Goedhals D., Louw V. HIV-associated Thrombotic Thrombocytopenic Purpura - what we know so far. Eur Oncol Haematol 2012, 8:89-91.
56. Harrison's principles of internal medicine 1994, McGraw-Hill, Inc., New York. 13th ed. K.J. Isselbacher, A.B. Braunwald, J.D. Wilson, J.B. Martin, A.S. Fauci, D.L. Kasper (Eds.).
57. Heyns A., Badenhorst P.N. Anemie. Bloedsiektes 1986, Academica, Kaapstad. A. Heyns, P.N. Badenhorst (Eds.).
58. Bain B.J. The blood count and film. Haematology: a core curriculum 2010, Imperial College Press, Singapore. B.J. Bain (Ed.).
59. Lawrie D., Coetzee L.M., Becker P., Mahlangu J., Stevens W., Glencross D.K. Local reference ranges for full blood count and CD4 lymphocyte count testing. S Afr Med J 2009, 99:243-248. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=19588777%26site=ehost-live.
60. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968, 405:5-37. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=4975372%26site=ehost-live.
61. Simon V., Ho D.D., Abdool Karim Q. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 2006, 368:489-504. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=16890836%26site=ehost-live.
62. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008, 372:293-299. Antiretroviral Therapy Cohort Collaboration. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=18657708%26site=ehost-live.
63. Harling G., Orrell C., Wood R. Healthcare utilization of patients accessing an African national treatment program. BMC Health Serv Res 2007, 7:80. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=17555564%26site=ehost-live.
64. Harling G., Wood R. The evolving cost of HIV in South Africa: changes in health care cost with duration on antiretroviral therapy for public sector patients. J Acquir Immune Defic Syndr 2007, 45:348-354. 10.1097/QAI.0b013e3180691115. http://journals.lww.com/jaids/Fulltext/2007/07010/The_Evolving_Cost_of_HIV_in_South_Africa__Changes.15.aspx.
65. Krentz H.B., Gill M.J. The direct medical costs of late presentation (<350/mm) of HIV infection over a 15-year period. AIDS Res Treat 2012, 2012:757135. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=21904673%26site=ehost-live.
66. Krentz H.B., Gill J. Despite CD4 cell count rebound the higher initial costs of medical care for HIV-infected patients persist 5 years after presentation with CD4 cell counts less than 350 μl. AIDS 2010, 24:2750-2753. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=20852403%26site=ehost-live.
67. Johansson L.M. Fiscal implications of AIDS in South Africa. Eur Econ Rev 2007, 1614-1640.
68. Adane A., Desta K., Bezabih A., Gashaye A., Kassa D. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia. Ethiop Med J 2012, 50:13-21. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=22519158%26site=ehost-live.
69. Berhane K., Karim R., Cohen M.H., et al. Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: women's interagency HIV study. J Acquir Immune Defic Syndr 2004, 37:1245-1252. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=15385731%26site=ehost-live.
70. Mildvan D., Creagh T., Leitz G. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study. Curr Med Res Opin 2007, 23:343-355. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=17288689%26site=ehost-live.
71. Murphy E.L., Collier A.C., Kalish L.A., et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 2001, 135:17-26. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=11434728%26site=ehost-live.
72. Derrick J.B. AIDS and the safety and adequacy of the Canadian blood supply. Can Anaesth Soc J 1986, 33:117-122. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=3516333%26site=ehost-live.
73. Barnes D.M. Keeping the AIDS virus out of blood supply. Science 1986, 233:514-515. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=3460177%26site=ehost-live.
74. Samuels M.E., Mann J., Koop C.E. Containing the spread of HIV infection: a world health priority. Public Health Rep 1988, 103:221-223. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=3131810%26site=ehost-live.
75. Aymard J.P., Janot C., Contal P., Linel C., Monange G., Streiff F. [Epidemiologic study of HIV serology in blood donors from 5 departments in northeastern France (1985-1989)]. Rev Fr Transfus Hemobiol 1989, 32:421-429. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=2629757%26site=ehost-live.
76. Vermeulen M., Lelie N., Sykes W., et al. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion 2009, 49:1115-1125. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=19309474%26site=ehost-live.
77. South African National Blood Service. Haemovigilance Report 2007. Johannesburg: South African National Blood Service, 2007.
78. South African National Blood Service. Haemovigilance Report 2010. Johannesburg: South African National Blood Service, 2010.
79. Ntusi N.B.A., Sonderup M.W. HIV/AIDS affects blood and blood product use at Groote Schuur Hospital, Cape Town. S Afr Med J 2011, 101:463-466. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=21920098%26site=ehost-live.
80. Ravry M.E., Paz H.L. The impact of HIV testing on blood utilization in the intensive care unit in patients with gastrointestinal bleeding. Intensive Care Med 1995, 21:933-936. http://search.ebscohost.com/login.aspx?direct=true%26db=mnh%26AN=8636526%26site=ehost-live.
81. Medical Directors of the South African Blood Transfusion Services Clinical guidelines for the use of blood products in South Africa 2008, 4th ed.